Germany Adjusts Amid BioNTech Vaccine Production Shift
The German government has announced that the loss of BioNTech vaccine production can be offset by other companies. Despite BioNTech closing sites and affecting jobs due to a strategic pivot, the government assures that vaccine supply remains secure.
- Country:
- Germany
The German government on Wednesday expressed confidence that the country's vaccine supply remains secure despite BioNTech's decision to close several production sites.
A government spokesperson confirmed that other companies are slated to compensate for the production shortfall as BioNTech shifts focus from pandemic-specific manufacturing.
BioNTech's recent announcement affects up to 1,860 jobs amid its strategic pivot away from COVID-19 vaccine production.
(With inputs from agencies.)
- READ MORE ON:
- BioNTech
- Germany
- vaccine
- production
- COVID-19
- government
- secure
- supply
- shift
- jobs
Advertisement
ALSO READ
Swiggy fails to secure requisite shareholder approval for altering AoA to become Indian-owned entity
Swiggy fails to secure requisite shareholder approval for altering AoA to become Indian-owned entity
Uganda suspends flights to D.R. Congo due to Ebola, government spokesman says hours
SIU Recovers Millions in COVID-19 School Sanitisation Scandal by Gauteng Education
Mumbai synthetic drug racket: NCB secures conviction of five, attaches Rs 6.5 cr worth assets
Google News